PTC Therapeutics, Inc. hosted a ribbon-cutting ceremony to recognize the official opening of its new gene therapy manufacturing facility in Hopewell, NJ.   PTC’s Hopewell facility is approximately 220,500 sq.-ft. of office, manufacturing and laboratory space, including state-of-the-art technology equipped to handle process development and manufacturing of plasmids and adeno-associated virus (AAV) vectors. The company is also offering world class plasmid DNA and AAV manufacturing services...